Newsroom Categories: Press release

  • Controversial SEC Proposal Would Rein in Large Shareholders Like Elon Musk

    Controversial SEC Proposal Would Rein in Large Shareholders Like Elon Musk

    PRESS RELEASE

    Controversial SEC Proposal Would Rein in Large Shareholders Like Elon Musk

    April 7, 2022

    Read time: 3 min

    Schulte Roth & Zabel partner Eleazer Klein was quoted in Yahoo! Finance on the SEC’s proposed rule change to narrow the disclosure window for activist investors in the wake of Elon Musk’s investment in Twitter. Stating that the SEC is “getting a lot of very, very strong pushback” from the investor community, Klein commented that “the change would strip away the effectiveness of activist investors, who identify and expose underperforming companies. Activists relying on a jump in stock price between the time of their purchase and the time following disclosure of their position should have the time needed to profit from their work…Other investors, he said, shouldn’t piggyback off of activists’ work.” On the specific conditions for Musk’s disclosure, Klein stated that “It’s unclear whether Musk qualifies as a traditional activist investor in Twitter…given that the company appears to have invited him onto its board. Traditional activists, he explained, generally campaign to replace board members.” For the full text article, click here.

     

    About Us

    Ele Klein

    Partner

    New York – 919 Third Avenue

    You may also like

  • Aymen Mahmoud Named In Global Restructuring Review’s 40 Under 40

    Aymen Mahmoud Named In Global Restructuring Review’s 40 Under 40

    AWARDS & RANKINGS / PRESS RELEASE

    Aymen Mahmoud Named In Global Restructuring Review’s 40 Under 40

    April 4, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery is pleased to announce that London-based partner Aymen Mahmoud and co-head of its London Finance, Restructuring and Special Situations Group, has been named in Global Restructuring Review’s (GRR) 40 Under 40 listing in 2022. You can view Aymen’s winner profile here.

    Aymen’s practice focuses on complex debt financing transactions and restructurings for private equity funds and their portfolio companies, hedge funds, corporate borrowers and issuers and other financial institutions. His experience includes acting in respect of direct lending, leveraged buyouts, domestic and cross-border syndicated senior, second lien and mezzanine lending, distressed debt trading, portfolio acquisitions, emerging markets and other debt securities, including high-yield debt offerings.

    Commenting on this illustrious recognition, Aymen Mahmoud, said:

    “I am humbled to be featured in this year’s GRR 40 under 40, especially as it is based on client and peer group feedback. I would like to thank all my mentors and friends that have guided and supported me in the past and the fantastic team at McDermott for their unwavering support and hard work. I’d also like to say a huge congratulations to those that I have the honour of being named alongside.”

    GRR is the trusted source of worldwide news and analysis for restructuring and insolvency practitioners. The “40 under 40” list recognises the world’s leading young insolvency and restructuring specialists.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Aymen Mahmoud

    Partner

    London – 22 Bishopsgate

    You may also like

  • McDermott Represents Kither Biotech in its EUR18.5m Founding Round

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Represents Kither Biotech in its EUR18.5m Founding Round

    April 1, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery advised Kither Biotech, an Italian biopharmaceutical company developing novel therapies for rare respiratory diseases, in its EUR18.5m Series B funding round. The funding will help accelerate clinical development of the company’s lead product (Kit2014) for the treatment of cystic fibrosis, as well as enable further expansion and diversifying the company’s range of products for the treatment of rare lung diseases.

    The group of new investors, led by Claris Ventures and 2Invest, assisted by 3B future health fund and Alef 6, also included some of the existing investors (Cdp Venture Capital Sgr, Italian Angels for Growth, Ersel, Club degli Investitori and Ace Venture) in the round.

    The McDermott team advising investor on this transaction was led by Ettore Scandale, partner in charge of the Italian corporate department, supported by associate Stefano Pardini and trainee Matteo Landini.

     

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Ettore Scandale

    Partner

    Milan

    You may also like

  • McDermott Advises Imfarr and SN Beteiligungen on Joint Acquisition of Former Post-bank-Karrees in Munich from Credit Suisse Asset Management

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Imfarr and SN Beteiligungen on Joint Acquisition of Former Post-bank-Karrees in Munich from Credit Suisse Asset Management

    April 1, 2022

    Read time: 3 min

    Frankfurt a.M., April 1, 2022 – McDermott Will & Emery advised Imfarr Beteiligungs GmbH of Austria and SN Beteiligungen Holding AG of Switzerland in connection with the financing of the acquisition and project development of the former Postbank-Karree from Credit Suisse.

    The former Postbank-Karree near Munich’s main train station will be transformed into a mod-ern office complex called “Elementum”, setting new urban accents in the. Among other things, the ensemble will consist of 67,000 square meters of office, retail and restaurant space, as well as 80 by 30 meters of hillside and woodland, in keeping with the concept of sustainability and climate protection. The total investment volume will be around 1 billion euros.

    A McDermott team led by Christoph Coenen and Kian Tauser advised on the tax structuring and financing of the acquisition and project development.

    Imfarr Beteiligungs GmbH is a family-owned company, founded in 2007 in Vienna, which specializes in real estate development and real estate investments in Austrian and German cities such as Vienna, Munich, Frankfurt, and Berlin.

    McDermott had already advised Imfarr Beteiligungs GmbH on the acquisition of the “Highlight Towers” in Munich, the Frankfurt “Silberturm”, the Nestlé Campus and Development Partner AG, among others. Here, too, the Swiss SN Beteiligungen Holding AG acted as co-investor. The Elementum transaction marks another highlight of the cooperation.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Christoph Coenen

    Partner

    Frankfurt

    Dr. Kian Tauser

    Partner

    Frankfurt

    Dr. Heiko Kermer

    Partner

    Frankfurt

    Dr. Philipp Grenzebach

    Partner

    Düsseldorf, Frankfurt

    Michael Spirk

    Associate

    Frankfurt

    You may also like

  • McDermott Advises Door2Door on Sale to Swvl

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Door2Door on Sale to Swvl

    March 31, 2022

    Read time: 3 min

    Düsseldorf, Germany, March 31, 2022 – McDermott Will & Emery advised Berlin-based mobility start-up Door2Door GmbH on the sale of all shares in the company to Dubai-based Swvl Inc. The transaction is expected to close within the second quarter of 2022.

    This is the first investment in the German market for transportation-as-a-service provider Swvl Inc. The company was launched five years ago in Cairo as a booking platform for local transport and now offers an app for booking bus rides in 115 cities worldwide. Via a SPAC, Swvl, which is valued at $1.5 billion, plans to go public on the New York Stock Exchange shortly.

    Door2Door offers complete solutions for a city’s local transport. This involves coordinating journeys using different means of transport. The offering is currently available in ten European countries.

    McDermott advised Door2Door from its founding through all financing rounds to its exit.

     

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Sebastian Bonk

    Partner

    Düsseldorf

    You may also like

  • McDermott advises Main Capital and Pointsharp on Acquisition of Cryptshare

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott advises Main Capital and Pointsharp on Acquisition of Cryptshare

    March 31, 2022

    Read time: 3 min

    Frankfurt a.M., March 31, 2022 – McDermott Will & Emery advised Main Capital Partners and its portfolio company Pointsharp on the acquisition of Cryptshare AG.

    The acquisition of the Freiburg-based cybersecurity specialist is the second add-on acquisition for Sweden-based Pointsharp since Main Capital’s entry in 2020, strengthening Pointsharp’s position as a leading security software provider in the European market with currently more than 3,000 customers.

    Cryptshare AG, founded in 2000 and headquartered in Freiburg, Germany, develops and sells software solutions for organizations, in particular a communication solution for the secure exchange of information.

    Main Capital Partners is a leading software investor in Benelux, German-speaking Europe and the Nordics with over €2.2 billion in assets under management (as of October 2021). Main has invested in more than 130 software companies to date.

    The McDermott team led by partner Norman Wasse is particularly experienced with software and tech transactions. The team advised Main Capital on various transactions, most recently on the acquisition of FormSolutions and DataPlan by machgruppe and Audimex by Swedish portfolio company Blika Solutions. McDermott Partner Dustin Schwerdtfeger is advising on all financing matters in connection with the transactions.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Dustin Schwerdtfeger

    Partner

    Düsseldorf

    Markus Hunkenschröder

    Associate

    Düsseldorf

    Dr. Johannes Honzen

    Partner

    Frankfurt

    Dr. Thomas Gennert

    Partner

    Düsseldorf

    Dr. Heiko Kermer

    Partner

    Frankfurt

    Marcus Fischer

    Counsel

    Frankfurt

    Christine Corkran Kretkowski

    Partner

    Washington, DC

    You may also like

  • McDermott Represents Spine BioPharma in $13 Million Series B Financing

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Represents Spine BioPharma in $13 Million Series B Financing

    March 30, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery represented Spine Biopharma, Inc, a biopharmaceutical company committed to developing non-opiate, non-surgical therapies for the treatment of pain and disability from chronic low back pain caused by degenerative disc disease, in the completion of its $13 million Series B equity financing.  The company intends to use the financing to support further development of SB-01 For Injection (SB-01) also known as Remedisc™, a first-in-class therapeutic for the treatment of degenerative disc disease.

    • The transaction was closed on March 17, 2022.
    • Read Spine Biopharma’s press release here.
    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Merrill M. Kraines

    Partner

    New York – One Vanderbilt Avenue

    Todd R. Kornfeld

    Partner

    New York – One Vanderbilt Avenue

    You may also like

  • McDermott Advises Five Arrows Direct Lending in a EUR 100 Million Fundraising for Oryx

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott Advises Five Arrows Direct Lending in a EUR 100 Million Fundraising for Oryx

    March 30, 2022

    Read time: 3 min

    McDermott Will & Emery has advised Five Arrows Direct Lending on the financing of Oryx Group’s shareholder restructuring through a new leveraged transaction.

    The Oryx Group is raising new unitranche debt from Five Arrows Direct Lending. The group of real estate agents is looking to expand internationally through the establishment of offices abroad, and aims to reach the EUR 300 million revenue milestone within five years.

    The McDermott team that advised Five Arrows Direct Lending comprised:

    • Pierre-Arnoux Mayoly, partner, Shirin Deyhim, counsel and Clarisse de Roux, associate, in financing.
    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Clarisse de Roux

    Associate

    Paris

    You may also like

  • Jerry Sokol and Dana Dombey Recognized with Daily Business Review’s Florida Legal Awards

    AWARDS & RANKINGS / PRESS RELEASE

    Jerry Sokol and Dana Dombey Recognized with Daily Business Review’s Florida Legal Awards

    March 29, 2022

    Read time: 3 min

    International law firm McDermott Will & Emery is pleased to announce that Miami-based Partners Jerry Sokol and Dana Dombey have been honored as part of the Daily Business Review’s Florida Legal Awards. Jerry has been named a Distinguished Leader, while Dana is honored within the On the Rise category.

    As one of the leading healthcare lawyers in the United States, Jerry has built a robust practice focused on the business aspects of healthcare law with an emphasis on mergers and acquisitions, private equity and various contractual arrangements in the industry. He is also a leader within McDermott, having served as the office managing partner for our Miami office from 2017 to 2021 and now serving as global head of the Healthcare practice. Jerry is also an active member of the Firm’s Management Committee.

    Speaking to her On the Rise recognition, Dana has a national practice focused on transactions and healthcare regulatory matters affecting healthcare companies and investors in the industry. Dana serves as practice area leader for McDermott’s Physician Practice Management (PPM) practice area, leader of the Healthcare Drafting Skills Workshop and a member of the Firm’s Diversity & Inclusion Committee, Recruiting Committee and Pro Bono and Community Service Committee.

    The Daily Business Review hosts its annual Florida Legal Awards to recognize distinguished members of the Florida legal community in assorted areas of the law. You can view the 2022 honorees here.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Jerry J. Sokol

    Partner

    Miami

    Dana Dombey

    Partner

    Miami

    You may also like

  • Acquisition of Audimex: McDermott advises Main Capital on first add-on acquisition for Blika Solutions

    Acquisition of Audimex: McDermott advises Main Capital on first add-on acquisition for Blika Solutions

    DEAL ANNOUNCEMENT / PRESS RELEASE

    Acquisition of Audimex: McDermott advises Main Capital on first add-on acquisition for Blika Solutions

    March 28, 2022

    Read time: 3 min

    Frankfurt a.M., March 28, 2022 – McDermott Will & Emery advised Main Capital Partners on the acquisition of Audimex AG by Main portfolio company Blika Solutions AB.

    The sellers are Audimex founders and board members, Stefan Berchtold and Markus Hövermann; both will remain on the management team and retain a partial stake through Blika.

    Main Capital Partners had acquired the Swedish software developer Blika in October 2021 and is now realizing its first add-on acquisition with the takeover of Audimex. The aim is to build an international software group specializing in solutions for governance, risk and compliance (GRC) processes.

    Audimex AG has been developing and selling software solutions for internal auditing and compliance since 1999. Blika Solutions AB offers a modular SaaS system that helps multinational companies comply with complex tax, legal and transfer pricing regulations.

    Main Capital Partners is a leading software investor in Benelux, German-speaking Europe, and Scandinavia with over €2.2 billion in assets under management. Main has invested in more than 120 software companies to date.

    The McDermott team, led by Norman Wasse and Dustin Schwerdtfeger, regularly assists Main Capital Partners in M&A transactions and financing.

    About Us

    McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

    Dustin Schwerdtfeger

    Partner

    Düsseldorf

    Markus Hunkenschröder

    Associate

    Düsseldorf

    Dr. Johannes Honzen

    Partner

    Frankfurt

    Dr. Thomas Gennert

    Partner

    Düsseldorf

    Dr. Heiko Kermer

    Partner

    Frankfurt

    Marcus Fischer

    Counsel

    Frankfurt

    Christine Corkran Kretkowski

    Partner

    Washington, DC

    You may also like